Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions

This publication has 13 references indexed in Scilit:

• Phase II Study of a Combination of Irinotecan and Cisplatin Against Metastatic Gastric Cancer
  Journal of Clinical Oncology, 1999
• Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactions
  Annals of Oncology, 1997
• Phase I Study of Paclitaxel by Three‐hour Infusion: Hypotension Just after Infusion Is One of the Major Dose‐limiting Toxicities
  Japanese Journal of Cancer Research, 1995
• Single agent Taxol, 3-hour infusion, in untreated advanced non-small-cell lung cancer
  Annals of Oncology, 1995
• Toxicity Grading Criteria of the Japan Clinical Oncology Group
  Japanese Journal of Clinical Oncology, 1993
• Taxol: A Novel Investigational Antimicrotubule Agent
  JNCI Journal of the National Cancer Institute, 1990
• Hypersensitivity reactions from taxol.
  Journal of Clinical Oncology, 1990
• Reporting results of cancer treatment
  Cancer, 1981
• Promotion of microtubule assembly in vitro by taxol
  Nature, 1979
• Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia
  Journal of the American Chemical Society, 1971